#1394 Endothelin-1 and cardio-kidney events among patients with CKD, diabetes, and anemia Article Swipe
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1093/ndt/gfaf116.0474
Background and Aims Endothelin-1 (ET-1) is a potent vasoconstrictor and is implicated in the pathogenesis of proteinuria and progressive chronic kidney disease (CKD). With the development of ET-1 receptor antagonists, there is interest in whether higher ET-1 concentrations are associated with a greater risk of adverse cardio-kidney events among high-risk patients, e.g., established chronic kidney disease (CKD) and type 2 diabetes (T2DM). Method Endothelin-1 concentrations were measured in a random subset of TREAT (n = 997 patients with CKD, T2DM, and anemia) using an automated ELISA assay on the Ella analyzer (ProteinSimple). We fit unadjusted and adjusted Cox regression models to explore the association of baseline serum ET-1 (log-transformed and quartiles) with heart failure, kidney events (composite of kidney failure or doubling of serum creatinine), and cardiovascular and all-cause death. Results Mean age was 67 ±10 years and 56% were female. The mean eGFR was 34 ± 11 mL/min/1.73 m2; median urine protein/creatinine ratio was 0.4 [0.1, 1.7] mg/mg; median ET-1 was 2.4 [1.9, 3.0] pg/mL. During a median follow-up of 2.4 years, there were 225 kidney events, 99 heart failure events, 124 cardiovascular deaths, and 188 all-cause deaths. Each log-unit higher ET1 was associated with a higher adjusted risk of the kidney composite (HR 1.61; 95% CI 1.08, 2.39), HF (HR 2.61; 95% CI 1.42, 4.81), but not with cardiovascular death (HR 1.06; 95% CI 0.65, 1.75) or all-cause death (HR 1.33; 95% CI 0.86, 2.04). Compared with the lowest quartile, categorical analyses suggested a higher risk of kidney events, HF events, and all-cause death for the highest quartile of ET-1 (Fig. 1). Conclusion Among patients with established CKD, T2DM, and anemia, higher baseline ET-1 was associated with a higher subsequent risk of kidney and heart failure and all-cause death. Whether higher ET-1 predicts responsiveness to ET-receptor antagonism warrants further investigation.
Related Topics
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1093/ndt/gfaf116.0474
- https://academic.oup.com/ndt/article-pdf/40/Supplement_3/gfaf116.0474/64833937/gfaf116.0474.pdf
- OA Status
- bronze
- OpenAlex ID
- https://openalex.org/W4415426751
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4415426751Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1093/ndt/gfaf116.0474Digital Object Identifier
- Title
-
#1394 Endothelin-1 and cardio-kidney events among patients with CKD, diabetes, and anemiaWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2025Year of publication
- Publication date
-
2025-10-01Full publication date if available
- Authors
-
Finnian R. Mc Causland, B Claggett, Petr Jarolı́m, Martina M. McGrath, Emmanuel A. Burdmann, Andrew S. Levey, John J.V. McMurray, Giuseppe Remuzzi, Scott D Solomon, Marc A. PfefferList of authors in order
- Landing page
-
https://doi.org/10.1093/ndt/gfaf116.0474Publisher landing page
- PDF URL
-
https://academic.oup.com/ndt/article-pdf/40/Supplement_3/gfaf116.0474/64833937/gfaf116.0474.pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
bronzeOpen access status per OpenAlex
- OA URL
-
https://academic.oup.com/ndt/article-pdf/40/Supplement_3/gfaf116.0474/64833937/gfaf116.0474.pdfDirect OA link when available
- Cited by
-
0Total citation count in OpenAlex
Full payload
| id | https://openalex.org/W4415426751 |
|---|---|
| doi | https://doi.org/10.1093/ndt/gfaf116.0474 |
| ids.doi | https://doi.org/10.1093/ndt/gfaf116.0474 |
| ids.openalex | https://openalex.org/W4415426751 |
| fwci | 0.0 |
| type | article |
| title | #1394 Endothelin-1 and cardio-kidney events among patients with CKD, diabetes, and anemia |
| biblio.issue | Supplement_3 |
| biblio.volume | 40 |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T10155 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.7598000168800354 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2737 |
| topics[0].subfield.display_name | Physiology |
| topics[0].display_name | Nitric Oxide and Endothelin Effects |
| topics[1].id | https://openalex.org/T10821 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.7311000227928162 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2705 |
| topics[1].subfield.display_name | Cardiology and Cardiovascular Medicine |
| topics[1].display_name | Cardiovascular Function and Risk Factors |
| topics[2].id | https://openalex.org/T11001 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.6897000074386597 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2705 |
| topics[2].subfield.display_name | Cardiology and Cardiovascular Medicine |
| topics[2].display_name | Renin-Angiotensin System Studies |
| is_xpac | False |
| apc_list.value | 3182 |
| apc_list.currency | EUR |
| apc_list.value_usd | 3431 |
| apc_paid | |
| language | en |
| locations[0].id | doi:10.1093/ndt/gfaf116.0474 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S186113128 |
| locations[0].source.issn | 0931-0509, 1460-2385 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 0931-0509 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Nephrology Dialysis Transplantation |
| locations[0].source.host_organization | https://openalex.org/P4310311648 |
| locations[0].source.host_organization_name | Oxford University Press |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310311648 |
| locations[0].license | |
| locations[0].pdf_url | https://academic.oup.com/ndt/article-pdf/40/Supplement_3/gfaf116.0474/64833937/gfaf116.0474.pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Nephrology Dialysis Transplantation |
| locations[0].landing_page_url | https://doi.org/10.1093/ndt/gfaf116.0474 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5026748157 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-0299-0533 |
| authorships[0].author.display_name | Finnian R. Mc Causland |
| authorships[0].countries | US |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I1283280774 |
| authorships[0].affiliations[0].raw_affiliation_string | Brigham and Women's Hospital, Boston, MA, USA |
| authorships[0].institutions[0].id | https://openalex.org/I1283280774 |
| authorships[0].institutions[0].ror | https://ror.org/04b6nzv94 |
| authorships[0].institutions[0].type | healthcare |
| authorships[0].institutions[0].lineage | https://openalex.org/I1283280774, https://openalex.org/I48633490 |
| authorships[0].institutions[0].country_code | US |
| authorships[0].institutions[0].display_name | Brigham and Women's Hospital |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Finnian R Mc Causland |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Brigham and Women's Hospital, Boston, MA, USA |
| authorships[1].author.id | https://openalex.org/A5001200438 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | B Claggett |
| authorships[1].countries | US |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I1283280774 |
| authorships[1].affiliations[0].raw_affiliation_string | Brigham and Women's Hospital, Boston, MA, USA |
| authorships[1].institutions[0].id | https://openalex.org/I1283280774 |
| authorships[1].institutions[0].ror | https://ror.org/04b6nzv94 |
| authorships[1].institutions[0].type | healthcare |
| authorships[1].institutions[0].lineage | https://openalex.org/I1283280774, https://openalex.org/I48633490 |
| authorships[1].institutions[0].country_code | US |
| authorships[1].institutions[0].display_name | Brigham and Women's Hospital |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Brian L Claggett |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Brigham and Women's Hospital, Boston, MA, USA |
| authorships[2].author.id | https://openalex.org/A5004666517 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-9612-8652 |
| authorships[2].author.display_name | Petr Jarolı́m |
| authorships[2].countries | US |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I1283280774 |
| authorships[2].affiliations[0].raw_affiliation_string | Brigham and Women's Hospital, Boston, MA, USA |
| authorships[2].institutions[0].id | https://openalex.org/I1283280774 |
| authorships[2].institutions[0].ror | https://ror.org/04b6nzv94 |
| authorships[2].institutions[0].type | healthcare |
| authorships[2].institutions[0].lineage | https://openalex.org/I1283280774, https://openalex.org/I48633490 |
| authorships[2].institutions[0].country_code | US |
| authorships[2].institutions[0].display_name | Brigham and Women's Hospital |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Petr Jarolim |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Brigham and Women's Hospital, Boston, MA, USA |
| authorships[3].author.id | https://openalex.org/A5057759766 |
| authorships[3].author.orcid | https://orcid.org/0000-0001-6210-9341 |
| authorships[3].author.display_name | Martina M. McGrath |
| authorships[3].countries | US |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I1283280774 |
| authorships[3].affiliations[0].raw_affiliation_string | Brigham and Women's Hospital, Boston, MA, USA |
| authorships[3].institutions[0].id | https://openalex.org/I1283280774 |
| authorships[3].institutions[0].ror | https://ror.org/04b6nzv94 |
| authorships[3].institutions[0].type | healthcare |
| authorships[3].institutions[0].lineage | https://openalex.org/I1283280774, https://openalex.org/I48633490 |
| authorships[3].institutions[0].country_code | US |
| authorships[3].institutions[0].display_name | Brigham and Women's Hospital |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Martina McGrath |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Brigham and Women's Hospital, Boston, MA, USA |
| authorships[4].author.id | https://openalex.org/A5068747774 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-7644-8579 |
| authorships[4].author.display_name | Emmanuel A. Burdmann |
| authorships[4].countries | BR |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I17974374 |
| authorships[4].affiliations[0].raw_affiliation_string | University of Sao Paulo Medical School, Sao Paulo, Brazil |
| authorships[4].institutions[0].id | https://openalex.org/I17974374 |
| authorships[4].institutions[0].ror | https://ror.org/036rp1748 |
| authorships[4].institutions[0].type | education |
| authorships[4].institutions[0].lineage | https://openalex.org/I17974374 |
| authorships[4].institutions[0].country_code | BR |
| authorships[4].institutions[0].display_name | Universidade de São Paulo |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Emmanuel Burdmann |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | University of Sao Paulo Medical School, Sao Paulo, Brazil |
| authorships[5].author.id | https://openalex.org/A5032690087 |
| authorships[5].author.orcid | https://orcid.org/0000-0003-1491-501X |
| authorships[5].author.display_name | Andrew S. Levey |
| authorships[5].countries | US |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I1290900354 |
| authorships[5].affiliations[0].raw_affiliation_string | Tufts Medical Center, Boston, MA, USA |
| authorships[5].institutions[0].id | https://openalex.org/I1290900354 |
| authorships[5].institutions[0].ror | https://ror.org/002hsbm82 |
| authorships[5].institutions[0].type | healthcare |
| authorships[5].institutions[0].lineage | https://openalex.org/I1290900354 |
| authorships[5].institutions[0].country_code | US |
| authorships[5].institutions[0].display_name | Tufts Medical Center |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Andrew Levey |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Tufts Medical Center, Boston, MA, USA |
| authorships[6].author.id | https://openalex.org/A5027213857 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-6317-3975 |
| authorships[6].author.display_name | John J.V. McMurray |
| authorships[6].countries | GB |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I7882870 |
| authorships[6].affiliations[0].raw_affiliation_string | University of Glasgow, Glasgow, UK |
| authorships[6].institutions[0].id | https://openalex.org/I7882870 |
| authorships[6].institutions[0].ror | https://ror.org/00vtgdb53 |
| authorships[6].institutions[0].type | education |
| authorships[6].institutions[0].lineage | https://openalex.org/I7882870 |
| authorships[6].institutions[0].country_code | GB |
| authorships[6].institutions[0].display_name | University of Glasgow |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | John McMurray |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | University of Glasgow, Glasgow, UK |
| authorships[7].author.id | https://openalex.org/A5023556434 |
| authorships[7].author.orcid | https://orcid.org/0000-0002-6194-3446 |
| authorships[7].author.display_name | Giuseppe Remuzzi |
| authorships[7].countries | IT |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I4210106645 |
| authorships[7].affiliations[0].raw_affiliation_string | Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy |
| authorships[7].institutions[0].id | https://openalex.org/I4210106645 |
| authorships[7].institutions[0].ror | https://ror.org/01savtv33 |
| authorships[7].institutions[0].type | healthcare |
| authorships[7].institutions[0].lineage | https://openalex.org/I4210106645 |
| authorships[7].institutions[0].country_code | IT |
| authorships[7].institutions[0].display_name | Ospedale Papa Giovanni XXIII |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Giuseppe Remuzzi |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy |
| authorships[8].author.id | https://openalex.org/A5108742388 |
| authorships[8].author.orcid | |
| authorships[8].author.display_name | Scott D Solomon |
| authorships[8].countries | US |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I1283280774 |
| authorships[8].affiliations[0].raw_affiliation_string | Brigham and Women's Hospital, Boston, MA, USA |
| authorships[8].institutions[0].id | https://openalex.org/I1283280774 |
| authorships[8].institutions[0].ror | https://ror.org/04b6nzv94 |
| authorships[8].institutions[0].type | healthcare |
| authorships[8].institutions[0].lineage | https://openalex.org/I1283280774, https://openalex.org/I48633490 |
| authorships[8].institutions[0].country_code | US |
| authorships[8].institutions[0].display_name | Brigham and Women's Hospital |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Scott Solomon |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Brigham and Women's Hospital, Boston, MA, USA |
| authorships[9].author.id | https://openalex.org/A5031560506 |
| authorships[9].author.orcid | https://orcid.org/0000-0003-3876-7568 |
| authorships[9].author.display_name | Marc A. Pfeffer |
| authorships[9].countries | US |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I1283280774 |
| authorships[9].affiliations[0].raw_affiliation_string | Brigham and Women's Hospital, Boston, MA, USA |
| authorships[9].institutions[0].id | https://openalex.org/I1283280774 |
| authorships[9].institutions[0].ror | https://ror.org/04b6nzv94 |
| authorships[9].institutions[0].type | healthcare |
| authorships[9].institutions[0].lineage | https://openalex.org/I1283280774, https://openalex.org/I48633490 |
| authorships[9].institutions[0].country_code | US |
| authorships[9].institutions[0].display_name | Brigham and Women's Hospital |
| authorships[9].author_position | last |
| authorships[9].raw_author_name | Marc Pfeffer |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Brigham and Women's Hospital, Boston, MA, USA |
| has_content.pdf | True |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://academic.oup.com/ndt/article-pdf/40/Supplement_3/gfaf116.0474/64833937/gfaf116.0474.pdf |
| open_access.oa_status | bronze |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-24T00:00:00 |
| display_name | #1394 Endothelin-1 and cardio-kidney events among patients with CKD, diabetes, and anemia |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10155 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.7598000168800354 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2737 |
| primary_topic.subfield.display_name | Physiology |
| primary_topic.display_name | Nitric Oxide and Endothelin Effects |
| cited_by_count | 0 |
| locations_count | 1 |
| best_oa_location.id | doi:10.1093/ndt/gfaf116.0474 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S186113128 |
| best_oa_location.source.issn | 0931-0509, 1460-2385 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 0931-0509 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Nephrology Dialysis Transplantation |
| best_oa_location.source.host_organization | https://openalex.org/P4310311648 |
| best_oa_location.source.host_organization_name | Oxford University Press |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310311648 |
| best_oa_location.license | |
| best_oa_location.pdf_url | https://academic.oup.com/ndt/article-pdf/40/Supplement_3/gfaf116.0474/64833937/gfaf116.0474.pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Nephrology Dialysis Transplantation |
| best_oa_location.landing_page_url | https://doi.org/10.1093/ndt/gfaf116.0474 |
| primary_location.id | doi:10.1093/ndt/gfaf116.0474 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S186113128 |
| primary_location.source.issn | 0931-0509, 1460-2385 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 0931-0509 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Nephrology Dialysis Transplantation |
| primary_location.source.host_organization | https://openalex.org/P4310311648 |
| primary_location.source.host_organization_name | Oxford University Press |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310311648 |
| primary_location.license | |
| primary_location.pdf_url | https://academic.oup.com/ndt/article-pdf/40/Supplement_3/gfaf116.0474/64833937/gfaf116.0474.pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Nephrology Dialysis Transplantation |
| primary_location.landing_page_url | https://doi.org/10.1093/ndt/gfaf116.0474 |
| publication_date | 2025-10-01 |
| publication_year | 2025 |
| referenced_works_count | 0 |
| abstract_inverted_index.2 | 60 |
| abstract_inverted_index.= | 75 |
| abstract_inverted_index.a | 7, 42, 69, 168, 197, 246, 280 |
| abstract_inverted_index.(n | 74 |
| abstract_inverted_index.11 | 148 |
| abstract_inverted_index.34 | 146 |
| abstract_inverted_index.67 | 135 |
| abstract_inverted_index.99 | 179 |
| abstract_inverted_index.CI | 208, 215, 226, 235 |
| abstract_inverted_index.HF | 211, 252 |
| abstract_inverted_index.We | 93 |
| abstract_inverted_index.an | 84 |
| abstract_inverted_index.in | 13, 34, 68 |
| abstract_inverted_index.is | 6, 11, 32 |
| abstract_inverted_index.of | 16, 27, 45, 72, 105, 118, 123, 171, 201, 249, 261, 284 |
| abstract_inverted_index.on | 88 |
| abstract_inverted_index.or | 121, 229 |
| abstract_inverted_index.to | 101, 297 |
| abstract_inverted_index.± | 147 |
| abstract_inverted_index.(HR | 205, 212, 223, 232 |
| abstract_inverted_index.0.4 | 156 |
| abstract_inverted_index.1). | 264 |
| abstract_inverted_index.124 | 183 |
| abstract_inverted_index.188 | 187 |
| abstract_inverted_index.2.4 | 163, 172 |
| abstract_inverted_index.225 | 176 |
| abstract_inverted_index.56% | 139 |
| abstract_inverted_index.95% | 207, 214, 225, 234 |
| abstract_inverted_index.997 | 76 |
| abstract_inverted_index.Cox | 98 |
| abstract_inverted_index.ET1 | 193 |
| abstract_inverted_index.The | 142 |
| abstract_inverted_index.age | 133 |
| abstract_inverted_index.and | 2, 10, 18, 58, 81, 96, 110, 126, 128, 138, 186, 254, 272, 286, 289 |
| abstract_inverted_index.are | 39 |
| abstract_inverted_index.but | 218 |
| abstract_inverted_index.fit | 94 |
| abstract_inverted_index.for | 257 |
| abstract_inverted_index.m2; | 150 |
| abstract_inverted_index.not | 219 |
| abstract_inverted_index.the | 14, 25, 89, 103, 202, 240, 258 |
| abstract_inverted_index.was | 134, 145, 155, 162, 194, 277 |
| abstract_inverted_index.1.7] | 158 |
| abstract_inverted_index.3.0] | 165 |
| abstract_inverted_index.Aims | 3 |
| abstract_inverted_index.CKD, | 79, 270 |
| abstract_inverted_index.ET-1 | 28, 37, 108, 161, 262, 276, 294 |
| abstract_inverted_index.Each | 190 |
| abstract_inverted_index.Ella | 90 |
| abstract_inverted_index.Mean | 132 |
| abstract_inverted_index.With | 24 |
| abstract_inverted_index.eGFR | 144 |
| abstract_inverted_index.mean | 143 |
| abstract_inverted_index.risk | 44, 200, 248, 283 |
| abstract_inverted_index.type | 59 |
| abstract_inverted_index.were | 66, 140, 175 |
| abstract_inverted_index.with | 41, 78, 112, 196, 220, 239, 268, 279 |
| abstract_inverted_index.±10 | 136 |
| abstract_inverted_index.(CKD) | 57 |
| abstract_inverted_index.(Fig. | 263 |
| abstract_inverted_index.0.65, | 227 |
| abstract_inverted_index.0.86, | 236 |
| abstract_inverted_index.1.06; | 224 |
| abstract_inverted_index.1.08, | 209 |
| abstract_inverted_index.1.33; | 233 |
| abstract_inverted_index.1.42, | 216 |
| abstract_inverted_index.1.61; | 206 |
| abstract_inverted_index.1.75) | 228 |
| abstract_inverted_index.2.61; | 213 |
| abstract_inverted_index.Among | 266 |
| abstract_inverted_index.ELISA | 86 |
| abstract_inverted_index.T2DM, | 80, 271 |
| abstract_inverted_index.TREAT | 73 |
| abstract_inverted_index.[0.1, | 157 |
| abstract_inverted_index.[1.9, | 164 |
| abstract_inverted_index.among | 49 |
| abstract_inverted_index.assay | 87 |
| abstract_inverted_index.death | 222, 231, 256 |
| abstract_inverted_index.e.g., | 52 |
| abstract_inverted_index.heart | 113, 180, 287 |
| abstract_inverted_index.ratio | 154 |
| abstract_inverted_index.serum | 107, 124 |
| abstract_inverted_index.there | 31, 174 |
| abstract_inverted_index.urine | 152 |
| abstract_inverted_index.using | 83 |
| abstract_inverted_index.years | 137 |
| abstract_inverted_index.(CKD). | 23 |
| abstract_inverted_index.(ET-1) | 5 |
| abstract_inverted_index.2.04). | 237 |
| abstract_inverted_index.2.39), | 210 |
| abstract_inverted_index.4.81), | 217 |
| abstract_inverted_index.During | 167 |
| abstract_inverted_index.Method | 63 |
| abstract_inverted_index.death. | 130, 291 |
| abstract_inverted_index.events | 48, 116 |
| abstract_inverted_index.higher | 36, 192, 198, 247, 274, 281, 293 |
| abstract_inverted_index.kidney | 21, 55, 115, 119, 177, 203, 250, 285 |
| abstract_inverted_index.lowest | 241 |
| abstract_inverted_index.median | 151, 160, 169 |
| abstract_inverted_index.mg/mg; | 159 |
| abstract_inverted_index.models | 100 |
| abstract_inverted_index.pg/mL. | 166 |
| abstract_inverted_index.potent | 8 |
| abstract_inverted_index.random | 70 |
| abstract_inverted_index.subset | 71 |
| abstract_inverted_index.years, | 173 |
| abstract_inverted_index.(T2DM). | 62 |
| abstract_inverted_index.Results | 131 |
| abstract_inverted_index.Whether | 292 |
| abstract_inverted_index.adverse | 46 |
| abstract_inverted_index.anemia) | 82 |
| abstract_inverted_index.anemia, | 273 |
| abstract_inverted_index.chronic | 20, 54 |
| abstract_inverted_index.deaths, | 185 |
| abstract_inverted_index.deaths. | 189 |
| abstract_inverted_index.disease | 22, 56 |
| abstract_inverted_index.events, | 178, 182, 251, 253 |
| abstract_inverted_index.explore | 102 |
| abstract_inverted_index.failure | 120, 181, 288 |
| abstract_inverted_index.female. | 141 |
| abstract_inverted_index.further | 301 |
| abstract_inverted_index.greater | 43 |
| abstract_inverted_index.highest | 259 |
| abstract_inverted_index.whether | 35 |
| abstract_inverted_index.Abstract | 0 |
| abstract_inverted_index.Compared | 238 |
| abstract_inverted_index.adjusted | 97, 199 |
| abstract_inverted_index.analyses | 244 |
| abstract_inverted_index.analyzer | 91 |
| abstract_inverted_index.baseline | 106, 275 |
| abstract_inverted_index.diabetes | 61 |
| abstract_inverted_index.doubling | 122 |
| abstract_inverted_index.failure, | 114 |
| abstract_inverted_index.interest | 33 |
| abstract_inverted_index.log-unit | 191 |
| abstract_inverted_index.measured | 67 |
| abstract_inverted_index.patients | 77, 267 |
| abstract_inverted_index.predicts | 295 |
| abstract_inverted_index.quartile | 260 |
| abstract_inverted_index.receptor | 29 |
| abstract_inverted_index.warrants | 300 |
| abstract_inverted_index.all-cause | 129, 188, 230, 255, 290 |
| abstract_inverted_index.automated | 85 |
| abstract_inverted_index.composite | 204 |
| abstract_inverted_index.follow-up | 170 |
| abstract_inverted_index.high-risk | 50 |
| abstract_inverted_index.patients, | 51 |
| abstract_inverted_index.quartile, | 242 |
| abstract_inverted_index.suggested | 245 |
| abstract_inverted_index.(composite | 117 |
| abstract_inverted_index.Background | 1 |
| abstract_inverted_index.Conclusion | 265 |
| abstract_inverted_index.antagonism | 299 |
| abstract_inverted_index.associated | 40, 195, 278 |
| abstract_inverted_index.implicated | 12 |
| abstract_inverted_index.quartiles) | 111 |
| abstract_inverted_index.regression | 99 |
| abstract_inverted_index.subsequent | 282 |
| abstract_inverted_index.unadjusted | 95 |
| abstract_inverted_index.ET-receptor | 298 |
| abstract_inverted_index.association | 104 |
| abstract_inverted_index.categorical | 243 |
| abstract_inverted_index.development | 26 |
| abstract_inverted_index.established | 53, 269 |
| abstract_inverted_index.mL/min/1.73 | 149 |
| abstract_inverted_index.progressive | 19 |
| abstract_inverted_index.proteinuria | 17 |
| abstract_inverted_index.Endothelin-1 | 4, 64 |
| abstract_inverted_index.antagonists, | 30 |
| abstract_inverted_index.creatinine), | 125 |
| abstract_inverted_index.pathogenesis | 15 |
| abstract_inverted_index.cardio-kidney | 47 |
| abstract_inverted_index.cardiovascular | 127, 184, 221 |
| abstract_inverted_index.concentrations | 38, 65 |
| abstract_inverted_index.investigation. | 302 |
| abstract_inverted_index.responsiveness | 296 |
| abstract_inverted_index.vasoconstrictor | 9 |
| abstract_inverted_index.(ProteinSimple). | 92 |
| abstract_inverted_index.(log-transformed | 109 |
| abstract_inverted_index.protein/creatinine | 153 |
| cited_by_percentile_year | |
| countries_distinct_count | 4 |
| institutions_distinct_count | 10 |
| citation_normalized_percentile.value | 0.62752294 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |